Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan flag Japan · Delayed Price · Currency is JPY
293.00
+3.00 (1.03%)
Apr 28, 2026, 3:30 PM JST
6.16%
Market Cap 14.72B
Revenue (ttm) 6.40B
Net Income (ttm) 923.00M
Shares Out 50.25M
EPS (ttm) 18.37
PE Ratio 15.95
Forward PE 22.64
Dividend 3.50 (1.21%)
Ex-Dividend Date Dec 29, 2025
Volume 80,800
Average Volume 75,010
Open 292.00
Previous Close 290.00
Day's Range 289.00 - 293.00
52-Week Range 239.00 - 444.00
Beta 0.32
RSI 47.25
Earnings Date May 15, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incor... [Read more]

Sector Healthcare
Founded 1946
Employees 220
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4574
Full Company Profile

Financial Performance

In 2025, Taiko Pharmaceutical's revenue was 6.40 billion, an increase of 1.67% compared to the previous year's 6.29 billion. Earnings were 923.00 million, an increase of 2.78%.

Financial Statements

News

There is no news available yet.